Otsuka Beijing Research Institute
36
0
2
33
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
2.8%
1 terminated/withdrawn out of 36 trials
97.1%
+10.6% vs industry average
44%
16 trials in Phase 3/4
0%
0 of 33 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (36)
PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes
Role: lead
a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects
Role: lead
Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol
Role: lead
Phase I Study Multi Dose of 7.5mg Tolvaptan in Health Male
Role: lead
To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD
Role: lead
Safety and Tolerability, and PK of Sibeprenlimab in Chinese Healthy Subject
Role: lead
Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia
Role: lead
Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
Role: lead
The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation
Role: lead
Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
Role: lead
Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
Role: lead
OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects
Role: lead
To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject
Role: lead
To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD
Role: lead
A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia
Role: lead
The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects
Role: lead
Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
Role: lead
The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects
Role: lead
OPC-61815 in Healthy Chinese Male Subjects
Role: lead
Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
Role: lead